TerminatedPhase 3NCT00746486

Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)

Studying Primary biliary cholangitis

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Dr. Falk Pharma GmbH
Principal Investigator: Raoul Poupon, Professor
Hôpital Saint-Antoine, 75571 Paris, France
Intervention: budesonide(drug)
Enrollment: 62 enrolled
Eligibility: 18 years · All sexes
Timeline: 2009 – 2019

Study locations (2)

Hôpital Saint-Antoine, Paris, France
Universitätsklinikum Bonn, Bonn, North Rhine-Westphalia, Germany

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00746486 on ClinicalTrials.gov

Other trials for Primary biliary cholangitis

Additional recruiting or active studies for the same condition.

See all trials for Primary biliary cholangitis →

← Back to all trials